Developed in partnership between Germany company BioNTech and US firm Pfizer, this is the fourth vaccine to receive such authorisation, following Oxford/AstraZeneca, Sputnik V, and Sinopharm’s Vero Cell.

The 500-bed Củ Chi COVID-19 Treatment Hospital in HCM City’s Củ Chi District on June 12 was officially put into use, and the COVID-19 Treatment Unit at Phạm Ngọc Thạch Hospital in District 5 will open on the 13th.